LAKELAND INDUSTRIES, INC.

LAKE ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $192.6M $167.2M $6.3M $6.0M $118.4M $159.0M $107.8M $99.0M
Cost of Revenue $129.3M $98.5M $73.5M $67.0M $67.5M $79.7M $69.9M $65.1M
Gross Profit $63.3M $68.7M $51.2M $45.8M $50.9M $79.3M $37.9M $33.9M
Gross Margin 32.9% 41.1% 812.6% 764.2% 43.0% 49.9% 35.2% 34.2%
Operating Expenses
Research & Development $200.0K $200.0K $200.0K
SG&A Expense
Operating Income $-15.5M $-9.3M $6.0M $5.5M $16.0M $43.9M $5.9M $3.6M
Operating Margin -8.1% -5.5% 95.1% 92.4% 13.6% 27.6% 5.5% 3.6%
Interest Expense $2.1M $1.7M $52.0K $37.0K $15.0K $23.0K $116.0K $125.0K
Pretax Income $-17.7M $-18.4M $9.4M $5.5M $16.2M $43.9M $5.8M $3.5M
Income Tax Expense $7.6M $-281.0K $3.9M $3.6M $4.8M $8.6M $2.5M $2.0M
Net Income $-25.3M $-18.1M $5.4M $1.9M $11.4M $35.3M $3.3M $1.5M
Net Margin -13.1% -10.8% 86.1% 31.2% 9.6% 22.2% 3.0% 1.5%
EPS (Basic) $-2.63 $-2.43 $0.74 $0.25 $1.44 $4.43 $0.41 $0.18
EPS (Diluted) $-2.63 $-2.43 $0.72 $0.24 $1.41 $4.34 $0.41 $0.18
Shares Outstanding (Basic) 9.6M 7.4M 7.4M 7.6M 7.9M 8.0M 8.0M 8.1M
Shares Outstanding (Diluted) 9.6M 7.4M 7.5M 7.7M 8.1M 8.1M 8.0M 8.2M
Dividends Per Share
← Newer Page 1 of 2 Older →